Regeneron Pharmaceuticals announced on Monday that it will buy 23andme for bankruptcy for $ 256 million – taking with it a wide range of genetic samples and data.
You will get the personal genome service for 23andme, health and total research services and large vital banks, including genetic data for more than 15 million customers – raising concerns related to privacy from individuals who have given good samples to the owners of different different.
Readon said that all genetic tests for 23andme will continue without interruption, and it is expected that the deal will be closed in the third quarter of 2025 pending bankruptcy approvals and organizational approvals.
The New York -based pharmaceutical company has pledged to remain compatible with the 23ndme bases for consumer stability and pledged to work with the Secretary of the Grievances appointed by the court, who will be achieved.
“We assure 23DME customers that we are committed to protecting the 23ndme data group through our high standards from the privacy of data, security and ethical control and you will provide their full potential to improve human health,” said Ares Barras, head of the Genetic Council in Rigneron, in a statement.
But the pharmaceutical company will get an unprecedented group of genetic data that was built since 23andme launched its direct test for the consumer in 2007.
Silicon Valley's evaluation at the same time-known as DNA testing tools and family trees that were automatically created-were evaluated after 6 billion dollars after published in 2021.
It has since declined to only 50 million dollars, partly due to a huge settlement of $ 30 million linked to the violation of data that is exposed to personal information for approximately 7 million users.
After the company applied for bankruptcy in March, the California Prosecutor Rob Ponta urged customers to delete their data from the 23andme database and demand the company to destroy any samples that are still being held before buying its assets company.
Customers can move to the settings in their 23ndme accounts to display and delete their data, and move to preferences to withdraw their approval to search and destroy any samples of stored saliva.
Anne Wojcikki, CEO of the ancestral testing company, has announced that it is stepped down from the company on the day of bankruptcy deposit after an internal dispute for months with the council for its proposal to take the private company.
All seven independent board members resigned 23andme in September in a bite reprimand to Wojcicki, a neighborhood of Yale who co -founded the company in 2006.
Besides the leadership of the famous genetic test company, whose groups once appeared in the annual Opera Winfrey menu from the favorite, WojCikki had many prominent relationships throughout her career.
She was married to the co -founder of Google Sergey Breen for eight years before her divorce in 2015, and she took the former Yankz star Alex Rodriguez from 2016 to 2017.
